Before we begin, I remind hon. Members to observe social distancing and to wear masks—apart from me, as I may have to speak at any moment. On Thursday, that guidance might change again, but that is what it says now.
I beg to move,
That the Committee has considered the draft Pneumoconiosis etc. (Workers’ Compensation) (Payment of Claims) (Amendment) Regulations 2022.
With this it will be convenient to consider the draft Mesothelioma Lump Sum Payments (Conditions and Amounts) (Amendment) Regulations 2022.
It is a pleasure to serve under your chairmanship, Ms Huq. Congratulations on joining the Panel of Chairs.
Important improvements in health and safety have restricted the use of asbestos and provided a much safer environment for those handling it. However, the legacy of its widespread use is of course still with us, with people starting to suffer many years—normally, decades—after exposure, when they can develop serious and often fatal diseases, such as diffuse mesothelioma. That long latency period can make it difficult for those affected, or their families, to bring a successful claim for civil damages—for example, because their former employer may simply no longer exist. They can, however, still claim compensation, through two schemes that aim, where possible, to ensure that people with diseases prescribed in regulations receive compensation in their lifetime, without having to wait for the outcome of civil litigation, which can take a long time.
There is the Pneumoconiosis etc. (Workers’ Compensation) Act 1979 scheme, which provides a lump sum to people who have one of five dust-related respiratory diseases, including diffuse mesothelioma, and who cannot claim damages from an employer because they have gone out of business. Rates are based on the level of the disablement assessment and the age of the person at diagnosis. There is also the 2008 mesothelioma lump sum payments scheme, established by the Child Maintenance and Other Payments Act 2008. That scheme was introduced to provide compensation to people with diffuse mesothelioma who could not claim compensation under the 1979 Act—for example, because they were self-employed or their asbestos exposure was not due to their work. Again, payments for mesothelioma are made at the 100% disablement rate and based on age, with the highest payments going to the youngest people with the disease. Under each scheme, a claim can be made by a dependant if the person with the disease has passed away. Overall, 2,670 awards were made across both schemes in 2020-21, with the awards totalling £42.4 million.
The Minister mentioned dependants. Consistently, both Opposition parties have raised the issue of the big disparities in compensation payments between sufferers and dependants, and we got a commitment from the Minister’s predecessor last year that the Government would look at that issue and look at providing an equality impact assessment on these benefits. Can this Minister please update us on that and what progress has been made to address the disparities between sufferers and dependants?
I can provide a very brief update. In the context of these regulations, that matter is not included, so it is not directly a matter for the Committee, but I am very much aware of the argument about equalisation. I am equally aware of the commitments that my predecessor gave, so with the Committee’s leave I will write to the hon. Gentleman to give him a little more detail, which goes beyond the scope of the regulations that we have here today.
The regulations increase the value of the lump sum awards payable under both schemes, which stand apart from the main social security benefits uprating procedure. Although there is no statutory requirement to increase the rates of these compensation schemes, I am maintaining the approach taken by my predecessors and increasing lump sum awards by the consumer prices index— 3.1%, as of September 2021. That is in line with the rate increase to the industrial injuries disablement benefit and the other disability benefits made as part of the main benefit operating provisions. The new levels will be paid to those who meet all the conditions for entitlement for the first time on or after 1 April this year.
I want to briefly mention further rule changes that we will make to support the end of life—sometimes known as the special rules for terminal illness. The Department certainly recognises the challenges that an individual, their friends and family face when they receive a terminal diagnosis. Supporting people in that difficult situation is, of course, crucial: that is why we have special rules for the end of life—to ensure that financial support can be provided as quickly as possible. These rules provide simple and fast access to benefits.
In July last year, we announced the intention to replace the current six-month rule for determining who could claim under those special rules with a 12-month end of life approach. That eligibility would then be consistent with current NHS end of life practice. Shortly, the Department plans to amend legislation to implement that change across five benefits, beginning with universal credit, alongside employment and support allowance. That will be followed, as soon as parliamentary time allows, by changes to the attendance allowance, the disability living allowance and the personal independence payment.
I will now touch on other support provided by the NHS for people with respiratory disease. As well as ensuring that financial compensation for the schemes is available, the Government are also focusing on and investing in support, protection, diagnosis, treatment and research. We also entirely acknowledge that the last two years have been a particularly challenging and worrying time for people with chronic respiratory conditions, which is why we prioritised people with such conditions and other vulnerable groups for the initial covid vaccination and booster programmes. We will offer a further fourth jab in the spring. It is also why the Department for Work and Pensions put in place temporary measures to protect the most vulnerable, including the suspension of face-to-face assessments at the start of the pandemic.
To qualify for an award under the 1979 scheme, people must have an entitlement to industrial injuries disablement benefit. We have continued these claims for people with diffuse mesothelioma and other illnesses as they can be assessed by paper. Other respiratory disease claims that could not be assessed by paper—those requiring lung function tests, for example—have now resumed, with extra safety measures in place.
We have introduced one-off special payments so that nobody loses out financially if their age goes up while waiting for an assessment, which would otherwise prevent them from getting the correct rate. It is important to be clear that all eligible awards for IIDB will be backdated to the date of claim. Of course, those awaiting IIDB assessment are still able to apply for other benefits if they find themselves in financial hardship or have care or mobility needs.
Looking to wider lung health, the NHS is also doing much to support the clinical priority of respiratory disease—within the cancer service recovery plan, for example. We expect the number of people diagnosed with mesothelioma to begin to fall in the coming years, but sadly many people will still develop it or other debilitating respiratory diseases. That is why we are working with the NHS to improve those people’s lives and why we recognise the continued importance of the financial compensation offered by the two schemes that we are discussing today. I commend the increase in the payment schemes to the Committee.
May I first apologise to you, Dr Huq, for omitting your doctorate earlier? That was an unintentional mistake.
Haven’t we all, Dr Huq? I thank you for chairing the debate, and I thank hon. Members for all their contributions, which I think have been in keeping with the seriousness of the work we are here to do on the regulations. I will endeavour to work through a number of the points that have been raised.
I reiterate my offer to write to the hon. Member for Ellesmere Port and Neston on equalisation and the other issues that he raised, and to copy in the entire Committee. I can of course confirm that the Government’s position is, as the hon. Gentleman pointed out, what was expressed in response to the parliamentary question: we think that the funds available ought to be prioritised for those who are suffering most with the diseases—the person with the disease. As I said, I will come back to the Committee to answer a few of the other points that have been made.
I also acknowledge the request made by the hon. Member for Glasgow South West about requiring an update on the Government’s wider work to support the safe management and removal of asbestos. I say again what I said to him two weeks ago in the Work and Pensions Committee: the Health and Safety Executive takes that extremely seriously and is, in my view, taking the right steps. I also reiterate my condolences to the hon. Gentleman for the loss of his friend.
The hon. Member for Arfon raised the geographical distribution of payments. I have some basic data that I can let him have right now, which is that Wales comprises 4% of scheme payments made by region in both 1979 and 2008. If we have it, I endeavour to come back to him with more granular data of interest to him.
I will cover a couple of the more legislative or philosophical points that were made. The hon. Member for Ellesmere Port and Neston asked why the uprating ought not to be automatic. I am conscious that, as has been said, that is an argument in its own right and it is made every year in these debates. The hon. Gentleman queried whether our having this debate every year is only a vehicle for those arguments or whether it serves any greater purpose. I take the view that this annual debate is valuable and gives us an opportunity to remember the gravity of the situation and to think about the human cost, as laid out well by the hon. Member for Reading East. However, turning from a consistent promise made across Governments of different persuasions to an automatic scheme would not necessarily make a difference to those who receive compensation. The money would rightly still come, and I do not take the argument that we need to make it automatic for that to be the case, because that commitment is there and has been there since 2004.
Moving on, the hon. Member for Ellesmere Port and Neston also questioned whether using CPI at 3.1% is enough. Since 2004, Ministers have uprated these schemes in line with inflation, so we have the argument of consistency and predictability, which is important in the sense that everybody knows that the CPI of September the prior year is what will be used.
Members may be aware from other aspects of inflation-uprating debates that my Department has some internal technical reasons that make it necessary to use the September rate. Those are important arguments, but the broader argument here is that to increase payments by inflation provides consistency and predictability and aligns the scheme with the way that other benefits are uprated.
I acknowledge that the hon. Member for Arfon also argued that the uprating date could be moved closer to that of the regulations, saying that that would give many of the same benefits. I will take that point away, because it could happen for all uprating across Government, which may be worth consideration.
The Government acknowledge that people are facing extra costs as a result of recent global price shocks. We already put in place extra support this winter in anticipation of higher costs, and we immediately responded to Ofgem’s announcement of the energy price cap increase. All that builds on extensive existing cost of living support that, crucially, is targeted at the most vulnerable, which is right. That reminds us of the context in which we are working—the hon. Member for Reading East rightly paid tribute to the organisations that assist in the understanding and promulgation of these important issues—and that we are doing this to support people who are very much in their hour of need. That is why we are all in agreement here today that uprating is the correct thing to do, and I again commend the regulations to the Committee.
Question put and agreed to.
Resolved,
That the Committee has considered the draft Pneumoconiosis Etc. (Workers’ Compensation) (Payment of Claims) (Amendment) Regulations 2022.
Draft Mesothelioma Lump Sum Payments (Conditions and Amounts) (Amendment) Regulations 2022
Resolved,
That the Committee has considered the draft Mesothelioma Lump Sum Payments (Conditions and Amounts) (Amendment) Regulations 2022.—(Chloe Smith.)